Building capacity for rigorous controlled trials in autism: The importance of measuring treatment adherence

MLA

Mcconachie, H., et al. Building Capacity for Rigorous Controlled Trials in Autism: The Importance of Measuring Treatment Adherence. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1308927252&authtype=sso&custid=ns315887.

APA

Mcconachie, H., Fletcher-Watson, S., Warreyn, P., Kaale, A., Rogé, B., Bonnet-Brilhaut, F., Oosterling, I., Ozdemir, S., Narzisi, A., Muratori, F., Fuentes, J., Heimann, M., Noterdaeme, M., Freitag, C., Poustka, L., Sinzig, J., Charman, T., Salomone, E., & Green, J. (2015). Building capacity for rigorous controlled trials in autism: The importance of measuring treatment adherence.

Chicago

Mcconachie, H, S Fletcher-Watson, P Warreyn, A Kaale, B Rogé, F Bonnet-Brilhaut, I Oosterling, et al. 2015. “Building Capacity for Rigorous Controlled Trials in Autism: The Importance of Measuring Treatment Adherence.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1308927252&authtype=sso&custid=ns315887.